(PDF) Efficacy, Safety, and Tolerability of Travoprost

Efficacy, Safety, and Tolerability of Travoprost 0.004% BAK-free Versus Prior Treatment With Latanoprost 0.005% in Japanese Patients

Clinical Ophthalmology - New Zealand

doi 10.2147/opth.s13460

Full Text

Open PDF

Abstract

Available in full text

Date

November 1, 2010

Authors

Unknown

Publisher

Informa UK Limited

Related search

First Experience With BAK-free Travoprost 0.004% in Topical Glaucoma Medication

Clinical Ophthalmology

Ophthalmology

2011

English

A Randomized Crossover Study Comparing Tafluprost 0.005% With Travoprost 0.004% in Patients With Normal-Tension Glaucoma

Clinical Ophthalmology

Ophthalmology

2012

English

Efficacy and Safety of a Switch to Latanoprost 0.005% + Timolol Maleate 0.5% Fixed Combination Eyedrops From Latanoprost 0.005% Monotherapy

Clinical Ophthalmology

Ophthalmology

2012

English

Efficacy of the Travoprost/Timolol Fixed Combination Versus the Concomitant Use of Travoprost 0.004% and Timolol 0.1% Gel Formulation

Clinical Ophthalmology

Ophthalmology

2018

English

Intraocular Pressure-Lowering Efficacy of Bimatoprost 0.03% and Travoprost 0.004% in Patients With Glaucoma or Ocular Hypertension

British Journal of Ophthalmology

Molecular Neuroscience

English

Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: A Rabbit Ocular Surface Study

English

Treatment of Glaucoma With the Fixed Combination of Latanoprost 0.005% and Timolol 0.5%

European Ophthalmic Review

2009

English

Safety and Tolerability of AZD5363 in Japanese Patients With Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology

English

Safety and Efficacy of Travoprost Solution for the Treatment of Elevated Intraocular Pressure

Clinical Ophthalmology

Ophthalmology

2015

English

Amanote Research

Efficacy, Safety, and Tolerability of Travoprost 0.004% BAK-free Versus Prior Treatment With Latanoprost 0.005% in Japanese Patients

Clinical Ophthalmology - New Zealand

doi 10.2147/opth.s13460

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

First Experience With BAK-free Travoprost 0.004% in Topical Glaucoma Medication

A Randomized Crossover Study Comparing Tafluprost 0.005% With Travoprost 0.004% in Patients With Normal-Tension Glaucoma

Efficacy and Safety of a Switch to Latanoprost 0.005% + Timolol Maleate 0.5% Fixed Combination Eyedrops From Latanoprost 0.005% Monotherapy

Efficacy of the Travoprost/Timolol Fixed Combination Versus the Concomitant Use of Travoprost 0.004% and Timolol 0.1% Gel Formulation

Intraocular Pressure-Lowering Efficacy of Bimatoprost 0.03% and Travoprost 0.004% in Patients With Glaucoma or Ocular Hypertension

Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: A Rabbit Ocular Surface Study

Treatment of Glaucoma With the Fixed Combination of Latanoprost 0.005% and Timolol 0.5%

Safety and Tolerability of AZD5363 in Japanese Patients With Advanced Solid Tumors

Safety and Efficacy of Travoprost Solution for the Treatment of Elevated Intraocular Pressure